Biodexa Pharmaceuticals (BDRX) Acquisitions (2015)

Biodexa Pharmaceuticals (BDRX) reported Acquisitions of $3.9 million for Q4 2015.

Biodexa Pharmaceuticals (BDRX) Acquisitions (2015) Analysis & Trends

Biodexa Pharmaceuticals (BDRX) has 1 years of Acquisitions data on file, last reported at $3.9 million in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Biodexa Pharmaceuticals 18.43 Bn 18.43 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2015 3.87 Mn